Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Skin Cancer Prevention 1Lung Neoplasms 1

Interventions

Cyclophosphamide 909Carboplatin 786Paclitaxel 741pembrolizumab 741Bevacizumab 715Cisplatin 707Gemcitabine 621Docetaxel 583Rituximab 558Radiotherapy 546Dexamethasone 510Nivolumab 488Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 357Pemetrexed 336Oxaliplatin 335Cytarabine 334Lenalidomide 327Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 315Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 275

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Motivational Interviewing × Clear all
NCT00580398 2018-10-12

Smoking Cessation Intervention for Thoracic Patients

Massachusetts General Hospital

Phase 1/2 Completed
49 enrolled 10 charts
Thoracic

Lung Neoplasms

NCT00709306 2018-08-31

The Skin Savvy Study: A Behavioral Skin Cancer Prevention Intervention

Fox Chase Cancer Center

Phase NA Completed
197 enrolled 11 charts
Dermatologic

Skin Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡